BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/26/2017 2:37:48 AM | Browse: 776 | Download: 1028
Publication Name World Journal of Meta-Analysis
Manuscript ID 32747
Country China
Received
2017-01-22 10:44
Peer-Review Started
2017-01-22 16:26
To Make the First Decision
2017-03-06 18:02
Return for Revision
2017-03-08 08:55
Revised
2017-05-05 23:07
Second Decision
2017-06-21 00:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-07-03 02:46
Articles in Press
2017-07-03 02:46
Publication Fee Transferred
2017-07-21 04:31
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-10-23 08:33
Publish the Manuscript Online
2017-10-25 07:20
ISSN 2308-3840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Thalidomide and thalidomide analogues in treatment of patients with inflammatory bowel disease: Meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Khan Rana Sami Ullah, Yu-Lin Xiong, Ying-Lei Miao, Ummair Saeed and Wei Dai
Funding Agency and Grant Number
Corresponding Author Wei Dai, Department of Gastroenterology, First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Digestive Disease, 295 Xichang Road, Kunming 650032, Yunnan Province, China. 1499016686@qq.com
Key Words Inflammatory bowel disease; Thalidomide; Thalidomide analogues; treatment; Efficacy; Safety; Meta-analysis
Core Tip The aim of this meta-analysis is to examine the efficacy and safety of thalidomide and thalidomide analogues for induction and maintenance of remission in patients with inflammatory bowel disease (IBD). The literature was searched in the databases: PubMed, EMBASE, Ovid and the Cochrane Library, and Chinese databases. The Randomized Controlled Trials was performed during this analysis to assess the effects of thalidomide therapy on IBD patients that did show good response with other therapies. Weighted pooled outcomes were synthesized with a fixed-effects model to account for clinical heterogeneity. This meta-analysis showed that there is not enough evidence to support the use of thalidomide or its analogues in the treatment of IBD for patients of any age.
Publish Date 2017-10-25 07:20
Citation Sami Ullah KR, Xiong YL, Dai W, Miao YL, Ummair SU. Thalidomide and thalidomide analogues in treatment of patients with inflammatory bowel disease: Meta-analysis. World J Meta-Analysis 2017; In press
URL http://www.wjgnet.com/2308-3840/full/v5/i5/124.htm
DOI http://dx.doi.org/10.13105/wjma.v5.i5.124
Full Article (PDF) WJMA-5-124.pdf
Full Article (Word) WJMA-5-124.doc
Manuscript File 32747-Review.docx
Answering Reviewers 32747-Answering reviewers.pdf
Audio Core Tip 32747-Audio core tip.m4a
Biostatistics Review Certificate 32747-Biostatistics statement.pdf
Copyright License Agreement 32747-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 32747-Language certificate.pdf
Peer-review Report 32747-Peer-review(s).pdf
Scientific Misconduct Check 32747-Scientific misconduct check.pdf
Scientific Editor Work List 32747-Scientific editor work list.pdf